Literature DB >> 18948387

Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.

Ralph J Coates, Katherine Kolor, Sherri L Stewart, Lisa C Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18948387     DOI： 10.1158/1078-0432.CCR-08-2296

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  10 in total

Review 1.  Molecular signatures of ovarian cancer: from detection to prognosis.

Authors:  Christine S Walsh; Beth Y Karlan
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

2.  Cancer: Missing the mark.

Authors:  Lizzie Buchen
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

Review 3.  Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.

Authors:  Colin M Court; Jacob S Ankeny; Shuang Hou; Hsian-Rong Tseng; James S Tomlinson
Journal:  Expert Rev Mol Diagn       Date:  2015-09-21       Impact factor: 5.225

4.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse.

Authors:  Kun-Ming Chen; Shang-Min Zhang; Cesar Aliaga; Yuan-Wan Sun; Timothy Cooper; Krishnegowda Gowdahalli; Junjia Zhu; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Res Toxicol       Date:  2012-01-06       Impact factor: 3.739

Review 5.  Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Authors:  Juliane M Liberto; Sheng-Yin Chen; Ie-Ming Shih; Tza-Huei Wang; Tian-Li Wang; Thomas R Pisanic
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

Review 6.  Effect of growth hormone on insulin signaling.

Authors:  Rita Sharma; John J Kopchick; Vishwajeet Puri; Vishva M Sharma
Journal:  Mol Cell Endocrinol       Date:  2020-09-20       Impact factor: 4.102

7.  Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers.

Authors:  Ping Yip; Tzong-Hao Chen; Partha Seshaiah; Laurie L Stephen; Karri L Michael-Ballard; James P Mapes; Brian C Mansfield; Greg P Bertenshaw
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

8.  [A retrospective study of ovarian cancer with a median follow of 42 months].

Authors:  Fanomezantsoa Raherinantenaina; Solonirina Davidà Rakotomena; Nomeharisoa Rodrigue Emile Hasiniatsy; Felantsoa Auberlin Rakototiana; Florine Rafaramino; Hery Nirina Rakoto Ratsimba
Journal:  Pan Afr Med J       Date:  2015-03-09

9.  Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study.

Authors:  Rafał Watrowski; Eva Obermayr; Christine Wallisch; Stefanie Aust; Nicole Concin; Elena Ioana Braicu; Toon Van Gorp; Annette Hasenburg; Jalid Sehouli; Ignace Vergote; Robert Zeillinger
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

10.  Phase II biomarker trial of a multimarker diagnostic for ovarian cancer.

Authors:  Tracey Edgell; G Martin-Roussety; G Barker; D J Autelitano; D Allen; P Grant; G E Rice
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-16       Impact factor: 4.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.